Nevertheless, we have to mention that in this early study, the HLA-DNA typing was carried out on a small sample of 45 patients with MS and 63 controls of different ethnic European groups (Swedish and Danish), using the Restriction Fragment Length Polymorphism (RFLP) technique for HLA-DP and HLA-DR genes. This evidence concerns the gene HLA-DPB1 and myeloid sarcoma.